XML 80 R62.htm IDEA: XBRL DOCUMENT v3.25.1
Business Concentrations (Details)
$ in Millions
12 Months Ended
Dec. 31, 2024
USD ($)
Theramex [Member]  
Business Concentrations [Line Items]  
Customer license revenue percentage 100.00%
Mayne Pharma [Member]  
Business Concentrations [Line Items]  
Royalty receivable short term portion $ 3.6
Royalty receivable long term portion $ 16.0